| The FinancialContent Network SocialPicks Community | MarketMinute Monitor | MarketMinute Market Updates | MarketMinute Stock News |
|
The Monday Edition- Fixed Income Strategy For This Week & Speculative Trade (ENCY) |
|
| Jun 11, 2007 05:19 AM UTC |
|
Tracked Blogger
|
Via Investment Ideas by Yaser Anwar:
I've finally got some spare time, so thought I'd share my thoughts on one wild week we're going to have.
___________ BTW: If you've got room in your portfolio to speculate with, take a look at ENCY (Highly Speculative)- ENCY's lead product Thelin has an FDA decision date of June 15, 2007. ENCY's main focus is on cardiovascular diseases. Thelin is already marketed in Europe and recently received a Canadian approval. It is highly likely Thelin will receive FDA approval. One potential problem for ENCY is Gilead has a similar drug up, Ambrisentan, for approval three days later and allegedly better than Thelin. However, if ENCY gets the nod you can expect the stock to pop 20-30% at least. ___________
Read the rest of original post »
|
|
|
IN THE PRESS |
|
|
|
|
|
|
| About | RSS | Feedback | Contact Us | Terms of Service | Privacy |
© 2009 FinancialContent Services, Inc. |
|
Data powered by FinancialContent. All Rights Reserved. Quotes delayed at least 20 minutes unless otherwise indicated. |
|
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. |